ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)

NCT01933529 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Type 2
Impaired Glucose Tolerance
Impaired Fasting Glucose

Interventions

DRUG: ARA 290

Sponsor

Claes-Göran Östenson

Collaborators

[object Object]